4271 - 4280 of 4301 Drugs
Viltepso (viltolarsen injection)
Viltepso (viltolarsen) is an antisense oligonucleotide used to treat Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.
Vinblastine Sulfate (vinblastine sulfate injection)
Vinblastine Sulfate for Injection is a stathmokinetic oncolytic agent used to treat cancer.
Vincristine Sulfate Injection (vincristine sulfate)
Vincristine sulfate injection is a cancer chemotherapy drug used to treat various types of cancer. Vincristine sulfate injection is usually used with other chemotherapy drugs to slow or stop cancer cell growth. The brand name of vincristine sulfate injection is discontinued, but generic versions may be available.
Vonvendi (von willebrand factor (recombinant) for injection)
Vonvendi [von Willebrand factor (recombinant)] for intravenous injection is a recombinant von Willebrand factor (VWF) indicated for on-demand treatment and control of bleeding episodes in adults diagnosed with von Willebrand disease.
Wilate (von willebrand factor/coagulation factor viii complex (human))
Wilate, von Willebrand Factor/Coagulation Factor VIII Complex (Human) is indicated in children and adults with von Willebrand disease for on-demand treatment and control of bleeding episodes and perioperative management of bleeding. Wilate is not indicated for treatment of hemophilia A.
Zontivity (vorapaxar tablets)
Zontivity (vorapaxar) is a PAR-1 antagonist, or an anti-platelet medication, used for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or with peripheral arterial disease (PAD).
Zolinza (vorinostat)
Zolinza (vorinostat) is an antineoplastic (anti-cancer) agent that works by slowing or stopping the growth of cancer cells and is used to treat skin problems caused by cutaneous T-cell lymphoma. Zolinza is usually given after other treatments have been tried without successful treatment of symptoms.